24th January 2022

$2.8m MRFF boost for vital cancer immunotherapy research

Mater Research will begin trialing a new targeted immunotherapy in 2022 to treat a rare but devastating blood cancer thanks to a $2.8m grant

Latest News

12 February 2021

Blood biomarker detects COVID-19 severity

A rapid, new blood test for COVID-19 is being commercialised.
More about Blood biomarker detects COVID-19 severity
12 February 2021

Creating predictive tools for lung cancer and COVID-19

QUT's TRI-based Dr Arutha Kulasinghe is developing new prognostic tests for cancers and COVID-19.
More about Creating predictive tools for lung cancer and COVID-19
23 November 2020

Genetic testing education could accelerate its potential

Dr Aideen McInerey-Leo finds public has low level of understanding of genetic testing
More about Genetic testing education could accelerate its potential
23 November 2020

Skin cancer treatment aims to help transplant patients

A new medication could help prevent organ transplant recipients from developing harmful skin cancers.
More about Skin cancer treatment aims to help transplant patients

Pages

Events

21 March 2022 9:30 AM6:00 PM

ASSC Genetics Summit 21 March 2022

The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit
More about ASSC Genetics Summit 21 March 2022

Upcoming Events

Sorry, no results found

Please try again with less restrictive search criteria